{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:13:38Z","timestamp":1777893218930,"version":"3.51.4"},"reference-count":25,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Background:<\/jats:title>\n Glioblastoma is the most common and aggressive primary malignant brain tumor in adults, with a poor prognosis despite multimodal treatment. This study aimed to describe the diagnostic aspects, therapeutic strategies, quality of life (QoL), and outcomes of patients operated on for glioblastoma at the Yaound\u00e9 General Hospital.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n This was a retrospective cohort study conducted at the Yaound\u00e9 General Hospital. Included were 32 patients who underwent surgery for glioblastoma with histological evidence from January 2018 to June 2025. Data were collected from medical records and analyzed using the Statistical Packages for the Social Sciences version 20. Comparisons between groups were performed using the Chi-square test or Student\u2019s t-test as appropriate. Survival distributions were compared using the Kaplan\u2013Meier method and the log-rank test. Statistical significance was set at\n P<\/jats:italic>\n < 0.05, and 95% confidence intervals were calculated for the main estimates. QoL was assessed using the Karnofsky and European Organization for Research and Treatment of Cancer QoL Questionnaire-C30 scores. Both assessments were performed during postoperative follow-up visits, specifically between the 1\n st<\/jats:sup>\n and the 6\n th<\/jats:sup>\n month after surgery. When available, preoperative Karnofsky scores recorded in medical files were also reviewed to assess functional improvement after surgery. Factors associated with QoL and outcomes were identified, and\n P<\/jats:italic>\n < 0.05 was considered significant. Overall survival was defined as the time interval between the date of histopathological confirmation of glioblastoma and the date of death or last follow-up.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Thirty-two patients were included, with a median age of 47.50 years (17.75; 59.75), a mean age of 42.9 \u00b1 13.8 years, and a female predominance (65.6%). The most common presenting symptom was neurologic deficit (68.8%). Magnetic resonance imaging was the main diagnostic modality (59.4%), and the tumor was most often located in the temporal lobe (30.8%). Surgery alone was performed in 56.3% of cases, whereas 25% received surgery followed by radiochemotherapy. The average overall survival was 10.2 months, increasing to 13.4 months in patients who received the full multimodal treatment. QoL scores were also better in this group. Age >60 was found to be significantly associated with poor outcomes.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Glioblastoma affects all ages in our setting. Combined therapeutic strategies, especially the addition of radiochemotherapy after surgery, were associated with longer survival and better QoL. Multidisciplinary management remains essential to improve outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/sni_972_2025","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:50:17Z","timestamp":1777618217000},"page":"251","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of life and outcomes of patients operated on for glioblastoma"],"prefix":"10.25259","volume":"17","author":[{"given":"Haman Nassourou","family":"Oumarou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foka Tacsing","family":"Bolivers Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu Ronaldo","family":"Fonju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislain","family":"Guea Ngbwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djientcheu","family":"Vincent De Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"10.25259\/SNI_972_2025\/ref-1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1073\/pnas.11.1.82","article-title":"Microchemical color reactions as an aid to the identification and classification of brain tumors","volume":"11","author":"Bailey","year":"1925","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.25259\/SNI_972_2025\/ref-2","first-page":"S24","article-title":"Glioblastoma: Changing concepts in the WHO CNS5 classification","volume":"65","author":"Chen","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"10.25259\/SNI_972_2025\/ref-3","first-page":"16","article-title":"Les tumeurs c\u00e9r\u00e9brales: Quel algorithme pour une prise en charge utile et efficiente \u00e0 l\u2019H\u00f4pital Central de Yaound\u00e9","volume":"13","author":"Djientcheu","year":"2019","journal-title":"? Med Afr Noire"},{"key":"10.25259\/SNI_972_2025\/ref-4","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s10143-022-01844-x","article-title":"Survival times of patients with glioblastoma in low-and middle-income countries: A systematic review and meta-analysis","volume":"45","author":"Dy","year":"2022","journal-title":"Neurosurg Rev"},{"key":"10.25259\/SNI_972_2025\/ref-5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuchi.2010.07.014","article-title":"Classification morphologique des glioblastomes","volume":"56","author":"Figarella-Branger","year":"2010","journal-title":"Neurochirurgie"},{"key":"10.25259\/SNI_972_2025\/ref-6","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: Genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev"},{"key":"10.25259\/SNI_972_2025\/ref-7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/jpm11040258","article-title":"Diagnosis and management of glioblastoma: A comprehensive perspective","volume":"11","author":"Gilard","year":"2021","journal-title":"J Personalized Med"},{"key":"10.25259\/SNI_972_2025\/ref-8","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.25259\/SNI_972_2025\/ref-9","first-page":"171","article-title":"The current survival and quality of life of patients diagnosed with glioblastoma in Yaounde","volume":"7","author":"Haman","year":"2025","journal-title":"J Neurol Neurochir Psychiatr Afr"},{"key":"10.25259\/SNI_972_2025\/ref-10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00165483","article-title":"Long-term survivors of glioblastoma multiforme: Clinical and molecular characteristics","volume":"27","author":"Morita","year":"1996","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_972_2025\/ref-11","first-page":"395","article-title":"Radial glial identity is promoted by notch1 signaling in the murine forebrain","volume":"26","author":"Nicholas","year":"2024","journal-title":"Neuron"},{"key":"10.25259\/SNI_972_2025\/ref-12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00701-025-06633-1","article-title":"Recurrence patterns and clinical outcomes in adult cerebellar glioblastoma","volume":"167","author":"Oki","year":"2025","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_972_2025\/ref-13","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_972_2025\/ref-14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/neuonc\/not002","article-title":"Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: Results of a prospective pilot study","volume":"15","author":"Pafundi","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_972_2025\/ref-15","article-title":"Ciblage du Glioblastome Multiforme par Les Inhibiteurs de BMI1","author":"Patrick","year":"2019","journal-title":"Universit\u00e9 de Montreal"},{"key":"10.25259\/SNI_972_2025\/ref-16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3747\/co.2007.147","article-title":"Gliadel wafers in the treatment of malignant glioma: A systematic review","volume":"14","author":"Perry","year":"2007","journal-title":"Curr Oncol"},{"key":"10.25259\/SNI_972_2025\/ref-17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/cancers17111837","article-title":"Fluorescence-guided surgery for gliomas: Past, present, and future","volume":"17","author":"Rodriguez","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.25259\/SNI_972_2025\/ref-18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ajco.12756","article-title":"Biomarkers and therapeutic advances in glioblastoma multiforme","volume":"14","author":"Sasmita","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.25259\/SNI_972_2025\/ref-19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.25259\/SNI_972_2025\/ref-20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_972_2025\/ref-21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.25259\/SNI_972_2025\/ref-22","first-page":"299","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.25259\/SNI_972_2025\/ref-23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_972_2025\/ref-24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.25259\/SNI_972_2025\/ref-25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jocn.2021.08.022","article-title":"Intraoperative radiotherapy for glioblastoma: A systematic review of techniques and outcomes","volume":"93","author":"Ylanan","year":"2021","journal-title":"J Clin Neurosci"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/quality-of-life-and-outcomes-of-patients-operated-on-for-glioblastoma\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/quality-of-life-and-outcomes-of-patients-operated-on-for-glioblastoma\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:50:20Z","timestamp":1777618220000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/quality-of-life-and-outcomes-of-patients-operated-on-for-glioblastoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":25,"alternative-id":["10.25259\/SNI_972_2025"],"URL":"https:\/\/doi.org\/10.25259\/sni_972_2025","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"251"}}